Vaginal adenoma

Summary

Vaginal adenoma (MONDO:0003434) is a cancer. A subtype of vaginal glandular neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	vaginal adenoma
Mondo ID	MONDO:0003434
DOID	DOID:5402
NCIT	C40256
UMLS	C1519913
MedGen	274377
Anatomy (UBERON)	UBERON:0000996
Is cancer (heuristic)	yes

Also known as: vagina adenoma · vaginal adenoma

Disease family

An umbrella term covering 2 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › vaginal disorder › vaginal neoplasm › vaginal glandular neoplasm › vaginal adenoma

Related subtypes (2): vaginal mullerian papilloma, vaginal adenocarcinoma

Subtypes (2): vaginal villous adenoma, vaginal tubulovillous adenoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.